Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10262-1 | L-779450 | LSM-4283 |  | 9950176 | |
| 10051-3 | Lapatinib | GW-572016; Tykerb | LSM-1051 |  | 208908 |
| 10263-1 | LBH589 | Panobinostat | LSM-4284 |  | 57519507 |
| 10230-2 | Lestaurtinib | CEP-701 | LSM-1231 |  | 126565 |
| 10510-1 | LY294002 | LY-294002 |  | 3973 | |
| 10511-1 | Mebendazole | Vermox |  | 4030 | |
| 10264-1 | Methotrexate | Rheumatrex; Trexall; Amethopterin; MTX | LSM-5690 |  | 126941 |
| 10512-1 | Methylglyoxal | Acetylformaldehyde; Pyruvaldehyde |  | 880 | |
| 10107-2 | MG-132 | LSM-1107 |  | 462382 | |
| 10107-5 | MG-132 | LSM-1107 |  | 462382 | |
| 10513-1 | Nelfinavir | Viracept |  | 64143 | |
| 10099-2 | Nilotinib | AMN-107 | LSM-1099 |  | 644241 |
| 10266-1 | NSC 663284 | LSM-2042 |  | 379077 | |
| 10267-1 | NU6102 | LSM-4287 |  | 4566 | |
| 10268-1 | Nutlin 3a | LSM-6351 |  | 11433190 | |
| 10344-1 | Olomoucine II | LSM-6356 |  | 10067756 | |
| 10146-2 | Omipalisib | GSK2126458; GSK2126458A | LSM-1147 |  | 25167777 |
| 10269-1 | Oxaliplatin | Eloxatin | LSM-44941 |  | 5310940 |
| 10270-1 | Oxamflatin | LSM-4290 |  | 4611 | |
| 10026-3 | PD173074 | LSM-1026 |  | 1401 | |
| 10048-7 | PD184352 | CI-1040 | LSM-1048 |  | 6918454 |
| 10048-6 | PD184352 | CI-1040 | LSM-1048 |  | 6918454 |
| 10271-2 | PD 98059 | LSM-3394 |  | 4713 | |
| 10272-1 | Pemetrexed | Alimta | LSM-6353 |  | 446556 |
| 10265-1 | Pevonedistat | MLN 4924; MLN-4924; MLN4924 | LSM-6263 |  | 16720766 |